Saquin SR Quetiapine 50 mg prolonged-release tablets

Manufacturer
Pharmathen International S.A.(GREECE)

Registraction Number
MAL24046034AZ

Content:

• Active Ingredient: Quetiapine 50 mg.

• Schizophrenia: Treatment of schizophrenia in adults and adolescents.
• Bipolar Disorder: Treatment of manic episodes associated with bipolar disorder, either alone or with other medications.
• Major Depressive Disorder: Used in combination with antidepressants to treat major depressive disorder in adults.

1. Dosage: Typically, one tablet daily, with or without food.
2. Consistency: Take the tablet at the same time each day.
3. Adherence: Do not miss doses, as this can increase the risk of relapse.
4. Monitoring: Regular monitoring of mental health status and side effects is recommended.